Article
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Proceedings of the National Academy of Sciences of the United States of America - 25 Jan 2005
Han Guangzhou, Buchanan Grant, Ittmann Michael, Harris Jonathan M, Yu Xiaoqing, Demayo Francesco J, Tilley Wayne, Greenberg Norman M
Abstract excerpt
Recent evidence demonstrates that the androgen receptor (AR) continues to influence prostate cancer growth despite medical therapies that reduce circulating androgen ligands to castrate levels and/or block ligand binding. Whereas the mutation, amplification, overexpression of AR, or cross-talk between AR and other growth factor pathways may explain the failure of androgen ablation therapies in some cases, there...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
